findmyKOL
Clinical trialNCT06041425CompletedPhase 4Interventional

The Effects of Oxycodone Versus Sufentanil on Pain and Inflammatory Response After TACE

SponsorThe First Affiliated Hospital with Nanjing Medical UniversityEnrollment40Hepatocellular CarcinomaInflammationPainTranscatheter Arterial Chemoembolization
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital With Nanjing Medical University

    Nanjing, Jiangsu, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Aug 2023
Primary completion
17 Dec 2023
Completion
25 Dec 2023
Last update posted
28 Feb 2024
Registered enrollment
40
Registry id
NCT06041425

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.